MORGAN STANLEY - HUMACYTE INC ownership

HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 84 filers reported holding HUMACYTE INC in Q3 2023. The put-call ratio across all filers is 63.87 and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of HUMACYTE INC
ValueSharesWeighting
Q3 2023$229,433
-13.4%
78,305
-15.5%
0.00%
Q2 2023$265,037
+13.4%
92,670
+22.5%
0.00%
Q1 2023$233,743
+125.8%
75,645
+54.2%
0.00%
Q4 2022$103,514
-32.3%
49,059
+4.5%
0.00%
Q3 2022$153,000
+18.6%
46,968
+17.0%
0.00%
Q2 2022$129,000
-57.0%
40,143
-5.8%
0.00%
Q1 2022$300,000
-55.0%
42,603
-53.6%
0.00%
Q4 2021$666,000
-20.7%
91,817
+26.9%
0.00%
Q3 2021$840,00072,3430.00%
Other shareholders
HUMACYTE INC shareholders Q3 2023
NameSharesValueWeighting ↓
Imprint Wealth LLC 257,119$938,4120.62%
Endowment Wealth Management, Inc. 96,618$298,5500.30%
Prescott General Partners LLC 568,246$1,755,8800.14%
HAMILTON LANE ADVISORS LLC 52,693$1630.06%
United Asset Strategies, Inc. 58,960$182,1860.02%
Kovack Advisors, Inc. 35,000$108,1500.02%
Shay Capital LLC 19,987$61,7600.01%
Y-Intercept (Hong Kong) Ltd 14,565$45,0060.01%
Mendota Financial Group, LLC 500$3,5300.00%
PHILADELPHIA TRUST CO 10,000$310.00%
View complete list of HUMACYTE INC shareholders